The phase 3 trial showed biosimilar CT-P42 (Celltrion) is therapeutically equivalent to reference aflibercept in improving ...
Nadi Tarangini, an indigenously developed pulse diagnostic tool, has become India’s first ayurvedic medical device to receive ...
Drugmaker Wockhardt on Thursday announced Central Drugs Standard Control Organization (CDSCO) approval for use of ... plans to launch Miqnaf in the Indian market in coming few months, Wockhardt ...
Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...
The CDSCO is India’s equivalent to the United States Food and Drug Administration (FDA ... SS Innovations has commenced the regulatory approval process in the United States and the European ...
India's new drug approval process waiver raises concerns about patient safety, research, and healthcare implications, experts ...
MannKind (MNKD) and Cipla announced that the Central Drugs Standard Control Organisation in India has approved Afrezza Inhalation Powder in adults. The CDSCO decision follows existing approvals in ...
CDSCO brings clinical trial site addition and change of PI applications to online mode: Gireesh Babu, New Delhi Thursday, January 2, 2025, 08:00 Hrs [IST] The Central Drugs Standa ...
However, regulatory approvals ... specific to the Indian population. In August 2024, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) reviewed Eli ...
Shares of Wockhardt are higher by 5% on January 3 after Indian drug regulator ... in an exchange filing. Central Drugs Standard Control Organization (CDSCO) approved antibiotic Nafithromycin ...
and Cipla Ltd. announced today that the Central Drugs Standard Control Organisation (CDSCO) in India has approved Afrezza (insulin human) Inhalation Powder in adults. The CDSCO decision follows ...
SS Innovations becomes the first and only company in India to receive regulatory approval for Telesurgery and Teleproctoring capabilities of a surgical robotic system, its SSi Mantra, marking a ...